Dr. Jacob is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
J3-4
Cleveland, OH 44195Phone+1 216-444-4036Fax+1 216-445-6192
Education & Training
- Cleveland Clinic FoundationFellowship, Advanced Heart Failure and Transplant Cardiology, 2010 - 2011
- Duke University HospitalResidency, Internal Medicine, 2003 - 2006
- University of Virginia School of MedicineClass of 2003
Certifications & Licensure
- OH State Medical License 2007 - 2026
- MD State Medical License 2011 - 2018
- NC State Medical License 2003 - 2008
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 409 citationsEvaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.Marvin A. Konstam, Michael S. Kiernan, Daniel Bernstein, Biykem Bozkurt, Miriam Jacob
Circulation. 2018-05-15 - 80 citationsAssociation of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).Neil Mehta, Ankur Kalra, Amy S Nowacki, Scott Anjewierden, Zheyi Han
JAMA Cardiology. 2020-09-01 - 52 citationsEffect of Timing of Chronic Preoperative Aspirin Discontinuation on Morbidity and Mortality in Coronary Artery Bypass SurgeryMiriam Jacob, Nicholas G. Smedira, Eugene H. Blackstone, Sarah J. Williams, Leslie Cho
Circulation. 2011-02-15
Journal Articles
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)Andres E Carmona-Rubio, Miriam Jacob, Gary W Procop, Mina K Chung, JAMA Cardiology
Authored Content
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
Press Mentions
- Hepatitis C-infected Organs Safe for Transplant, Saving LivesMarch 21st, 2019
- Persistent Cough? It May Be a Sign of Heart FailureDecember 28th, 2018
- Total Artificial Heart as Bridge to Transplant in Biventricular Heart FailureFebruary 24th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: